Neutron dose evaluation in conventional and FLASH proton therapy
DOI:
https://doi.org/10.15392/2319-0612.2023.2081Keywords:
Protontherapy, Flash, NeutronsAbstract
Cancer is the second leading cause of death for children and one of the treatment options for this disease is radiotherapy. Children treated with radiotherapy using photon beams are more likely to develop secondary neoplasms. Proton therapy can reduce the probability of neoplasm formation by up to 50%. Recent studies propose the use of ultra high dose rates as a treatment option. From the threshold of 40 Gy/s it is possible to reach the FLASH effect. This technique protects healthy tissue while maintaining tumor control. The effect was validated in vivo using a proton beam and, therefore, it will be available as a new treatment option. On the other hand, the proposal for FLASH treatment with a proton beam would not use the Bragg peak located in the target volume, which is the differential of proton radiotherapy. In addition, the increase in the intensity of the beam and the energy of the particles, lead to the generation of a greater amount of neutrons. The objective of this work is to evaluate the dose due to the neutrons generated in the interaction with the accelerator components in FLASH proton therapy in relation to conventional proton therapy. The dose evaluation was performed through Monte Carlo simulations, using a water phantom, with the code TOPAS MC. The results found show that the dose of neutrons in the FLASH technique would be about 100 times greater than the dose in the conventional technique. Still, it would be below 1% of the prescribed dose.
- Views: 336
- PDF Downloads: 286
- XML Downloads: 33
Downloads
References
GREENBERGER, B.A.; YOCK, T.I. The role of proton therapy in pediatric malignancies: Recent advances and future directions. In: Seminars in Oncology. WB Saunders, 2020. p. 8-22. DOI: https://doi.org/10.1053/j.seminoncol.2020.02.002
FRIEDMAN, D.L. et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. JNCI: Journal of the National Cancer Institute, v. 102, n. 14, p. 1083-1095, 2010. DOI: https://doi.org/10.1093/jnci/djq238
ÁLVAREZ, S.I.P. et al. Proton Therapy in Lower-Middle-Income Countries: From Facts and Reality to Desire, Challenges and Limitations. In: Proton Therapy-Current Status and Future Directions. IntechOpen, 2021.
WILSON, R.R. Radiological Use of Fast Protons. Radiology 47(5), 487-91 (1946). DOI: https://doi.org/10.1148/47.5.487
ENGELSMAN M.; SCHWARZ M.; DONG L. Physics controversies in proton therapy. In: Seminars in radiation oncology. WB Saunders, 2013. p. 88-96. DOI: https://doi.org/10.1016/j.semradonc.2012.11.003
MATSUMOTO, S. et al. Secondary neutron doses to pediatric patients during intracranial proton therapy: Monte Carlo simulation of the neutron energy spectrum and its organ doses. Health Physics, v. 110, n. 4, p. 380-386, 2016. DOI: https://doi.org/10.1097/HP.0000000000000461
SCHNEIDER, U. et al. Secondary neutron dose during proton therapy using spot scanning. International Journal of Radiation Oncology* Biology* Physics, v. 53, n. 1, p. 244-251, 2002. DOI: https://doi.org/10.1016/S0360-3016(01)02826-7
VOZENIN, M.C. et al. The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clinical Cancer Research, v. 25, n. 1, p. 35-42, 2019. DOI: https://doi.org/10.1158/1078-0432.CCR-17-3375
BOURHIS, J. et al. Clinical translation of FLASH radiotherapy: Why and how?. Radiotherapy and Oncology, v. 139, p. 11-17, 2019. DOI: https://doi.org/10.1016/j.radonc.2019.04.008
FAVAUDON, V.; FOUILLADE, C.; VOZENIN, M.-C. Radiothérapie «flash» à très haut débit de dose: un moyen d’augmenter l’indice thérapeutique par minimisation des dommages aux tissus sains?. Cancer/Radiothérapie, v. 19, n. 6-7, p. 526-531, 2015. DOI: https://doi.org/10.1016/j.canrad.2015.04.006
DIFFENDERFER, E.S. et al. Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system. International Journal of Radiation Oncology* Biology* Physics, v. 106, n. 2, p. 440-448, 2020. DOI: https://doi.org/10.1016/j.ijrobp.2019.10.049
PERL, J. et al. TOPAS: an innovative proton Monte Carlo platform for research and clinical applications. Medical physics, v. 39, n. 11, p. 6818-6837, 2012. DOI: https://doi.org/10.1118/1.4758060
JARLSKOG, Christina Zacharatou; PAGANETTI, Harald. Physics settings for using the Geant4 toolkit in proton therapy. IEEE Transactions on nuclear science, v. 55, n. 3, p. 1018-1025, 2008. DOI: https://doi.org/10.1109/TNS.2008.922816
PÉREZ-ANDÚJAR, A.; NEWHAUSER, W. D.; DELUCA JR., P. M. Contribution to Neutron Fluence and Neutron Absorbed Dose from Double Scattering Proton Therapy System Components. Nuclear Technology, v. 168, n. 3, p. 728-735, Maio 2009. DOI: https://doi.org/10.13182/NT09-A9297
YAN, H. et al. Accurate and Facile Determination of the Index of Refraction of Organic Thin Films Near the 1s Absorption Edge. Physical Review Letters, v. 110, n. 17, p. 177401, Abril 2013. DOI: https://doi.org/10.1103/PhysRevLett.110.177401
HARDING, G. L.; DU, J. Design and properties of quartz-based Love wave acoustic sensors incorporating silicon dioxide and PMMA guiding layers. Smart materials and structures, v. 6, n. 6, p. 716, 1997. DOI: https://doi.org/10.1088/0964-1726/6/6/008
SOUZA, F.M.L. Protonterapia : avaliação de dose absorvida de nêutrons nas técnicas de espalhamento duplo passivo convencional e FLASH. Trabalho de Conclusão de Curso (Bacharelado em Física Médica) – Instituto de Física, Universidade Federal do Rio de Janeiro. Rio de Janeiro, p. 53. 2022.
ANDERSON, H.H.; ZIEGLER, J.F. The Stopping and Ranges of Ions in Matter, New York: Pergamon, vol. 3, 1977.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
